Metraipolis › archive › dc_601239e1867a

Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42194027
DOI
10.3390/biom16050677
License (as archived)
solo-consultazione
Archived
2026-11-02T21:13:27.166Z
SHA-256 of the archived text
258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3
Stable URL of this page
https://metraipolis.com/documento/dc_601239e1867a

How to cite

Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027 — Europe PMC (en), https://europepmc.org/article/MED/42194027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_601239e1867a (Metraipolis archive dc_601239e1867a, sha256 258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3)
BibTeX
@misc{dc601239e1867a,
  title = {Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_601239e1867a; sha256 258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194027. Agents can read the archived copy with the MCP tool read_document.